Status:

COMPLETED

A Randomized Controlled Trial of Imago Relationship Therapy

Lead Sponsor:

University of Pennsylvania

Conditions:

Relationship Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary goal of this study, A Randomized Controlled Trial of Imago Relationship Therapy, is to evaluate the efficacy of Imago Relationship Therapy, a form of couples therapy.

Detailed Description

Imago relationship therapy (IRT; Hendrix, 2008) is an integrative approach to couples therapy that has been practiced and extensively disseminated for more than 30 years. IRT may be delivered through ...

Eligibility Criteria

Inclusion

  • Straight or LGBTQ couples; both members at least 18 years of age
  • Ability to speak and understand, and read and write, in English language
  • Married/cohabitating for a minimum of 1 year
  • Currently experiencing relationship distress
  • Interest in improving relationship satisfaction/have no immediate plans to terminate the relationship
  • Willingness to participate in study procedures via telehealth and access to the equipment and pricacy required to do so.

Exclusion

  • Current alcohol or substance dependence (with active use) in one or both partners
  • Serious suicidal ideation and behavior in one or both partners (i.e., ideation with plan or intent)
  • Current physical violence or partner abuse
  • One or both partners currently involved in a secret affair (i.e., the partner is unaware of this relationship)
  • Current couples-focused psychotherapy treatment that is on-going
  • Couple received IRT or GTLYW workshop within the past 5 years

Key Trial Info

Start Date :

March 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 16 2023

Estimated Enrollment :

132 Patients enrolled

Trial Details

Trial ID

NCT04302844

Start Date

March 4 2019

End Date

July 16 2023

Last Update

July 19 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mood and Anxiety Disorders Treatment & Research Program

Philadelphia, Pennsylvania, United States, 19104